Hospital News and Research

RSS

Study assesses risk factors for suicide among health care professionals

Health care professionals who die by suicide are more likely to be older and nearing the end of their careers, or be of Asian or Pacific Islander ancestry, or confronting physical, mental health or medical malpractice issues, according to a new study from Massachusetts General Hospital.

11 Jun 2020

Jane and Aatos Erkko Foundation awards 1.5 million euros to support breast cancer study

1.5 million euros funding supports a new investigator-initiated breast cancer clinical trial in Finland that takes on MYC.

11 Jun 2020

Federal help falters as nursing homes run short of protective equipment

Around the country, nursing homes trying to protect their residents from the coronavirus eagerly await boxes of masks, eyewear and gowns promised by the federal government. But all too often the packages deliver disappointment — if they arrive at all.

11 Jun 2020

A family with five doctors — and two COVID deaths

On the morning of April 1, Dr. Priya Khanna inched her way from the bedroom to the front door, using walls, doors and railings to hold herself up long enough to get to the stretcher waiting outside. She had been battling COVID-19 for five days and was struggling to breathe.

11 Jun 2020

Using stories to mentally survive as a COVID-19 clinician

Dr. Christopher Travis, an intern in obstetrics-gynecology, has cared for patients with COVID-19 and performed surgery on women suspected of having the coronavirus. But the patient who arrived for a routine prenatal visit in two masks and gloves had a problem that wasn’t physiological.

11 Jun 2020

Advancements in the Optimization of Medical Accelerators

Radiotherapy is a way of treating cancer by means of radiation. In principle, that can be all different types of radiation. The commonly known types are X-rays or electron beams, which find very widespread application.

11 Jun 2020

Hydroxychloroquine suppresses 'trained immunity'

A new study published on the preprint server medRxiv in June 2020 shows that the drug hydroxychloroquine (HCQ) suppresses a form of immunity called ‘trained immunity,’ with repercussions for its potential use to treat COVID-19.

11 Jun 2020

New methods to study the impacts of puberty suppression in brains of transgender youth

A new set of expert consensus-based recommendations lays out how best to study possible neurodevelopmental impacts of pubertal suppression treatment in transgender youth.

11 Jun 2020

Females mount stronger T-cell response to SARS-CoV-2

A new study published on the preprint server medRxiv in June 2020 shows that immune cells, antibody levels, cytokine levels, and viral loads contribute to the sex difference seen in response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

10 Jun 2020

Decisions made for incapacitated patients often not compatible with care requested by families

Researchers from Regenstrief Institute and Indiana University report that nearly half of the time medical treatments and orders received for incapacitated patients were not compatible with goals of care requested by their surrogate decision makers.

10 Jun 2020

Cannabis poisonings in children results from intentional use along with alcohol, illicit drugs

Most cannabis poisoning incidents involving children resulted from the intentional use of cannabis combined with alcohol, illicit drugs and/or medication, new research suggests.

10 Jun 2020

Study investigates potential of adoptive cell therapy in combination with checkpoint inhibitors

Volume 11, Issue 22 of @Oncotarget reported that there are rationale and evidence supporting immune therapy in Ovarian Cancers.

10 Jun 2020

Hyperprogression to immune blockade followed by a response with cabozantinib in metastatic RCC

Volume 11, Issue 22 of @Oncotarget reported that more and more patients receive first-line treatment with immunotherapy combinations and not all patients respond in metastatic renal cell carcinoma.

10 Jun 2020

Anticardiolipin antibodies and COVID-19

A new study has shown that anticardiolipin antibodies are associated with the novel coronavirus infection or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes COVID-19.

10 Jun 2020

Mozart listening associated with reduced seizure frequency in patients with epilepsy

A new clinical research study by Dr. Marjan Rafiee and Dr. Taufik Valiante of the Krembil Brain Institute at Toronto Western Hospital, part of University Health Network, has found that a Mozart composition may reduce seizure frequency in patients with epilepsy.

10 Jun 2020

New guidance for surgeons and clinicians working during COVID-19

Professor Björn Brücher is a cancer surgeon/scientist and the Editor in Chief of the EDP Sciences journal 4open. With 34 colleagues from around the world, he has created a clear guidance document for surgeons and clinicians working in the time of COVID-19, whether they are in a large state-of-the art hospital or a small clinic in a developing country.

10 Jun 2020

Cleveland Clinic receives $7.2 million to improve accuracy of MS diagnoses

The National Institutes of Health has awarded $7.2 million to a Cleveland Clinic-led research team to improve accuracy of multiple sclerosis (MS) diagnoses.

10 Jun 2020

Tocilizumab in Critical COVID-19 Patients

A new study by scientists at Metro Infectious Disease Consultants and published on the preprint server medRxiv* in June 2020 reports that the cytokine blocker tocilizumab is a useful adjunct to supportive medical care in severe COVID-19, with increased survival and a lower requirement for mechanical ventilation.

10 Jun 2020

Study shows safety of new cell therapy approaches for kidney transplant recipients

A large international study coordinated by University Hospital Regensburg and Charité - Universitätsmedizin Berlin has demonstrated the safety of new cell therapy approaches for use in kidney transplant recipients.

10 Jun 2020

Specific immune signature identified in COVID-19 patients

Researchers at King’s College London and collaborators have identified an “immune signature” that could help researchers better understand coronavirus disease 2019 (COVID-19) and serve as a valuable resource for predicting patient prognosis and informing clinical risk-based stratification.

10 Jun 2020

Hospital News and Research

Study assesses risk factors for suicide among health care professionals

Jane and Aatos Erkko Foundation awards 1.5 million euros to support breast cancer study

Federal help falters as nursing homes run short of protective equipment

A family with five doctors — and two COVID deaths

Using stories to mentally survive as a COVID-19 clinician

Advancements in the Optimization of Medical Accelerators

Hydroxychloroquine suppresses 'trained immunity'

New methods to study the impacts of puberty suppression in brains of transgender youth

Females mount stronger T-cell response to SARS-CoV-2

Decisions made for incapacitated patients often not compatible with care requested by families

Cannabis poisonings in children results from intentional use along with alcohol, illicit drugs

Study investigates potential of adoptive cell therapy in combination with checkpoint inhibitors

Hyperprogression to immune blockade followed by a response with cabozantinib in metastatic RCC

Anticardiolipin antibodies and COVID-19

Mozart listening associated with reduced seizure frequency in patients with epilepsy

New guidance for surgeons and clinicians working during COVID-19

Cleveland Clinic receives $7.2 million to improve accuracy of MS diagnoses

Tocilizumab in Critical COVID-19 Patients

Study shows safety of new cell therapy approaches for kidney transplant recipients

Specific immune signature identified in COVID-19 patients

Industry Focus eBook - Cell biology (5th edition) eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News